Literature DB >> 20206987

Community-associated meticillin-resistant Staphylococcus aureus.

Frank R DeLeo1, Michael Otto, Barry N Kreiswirth, Henry F Chambers.   

Abstract

Meticillin-resistant Staphylococcus aureus (MRSA) is endemic in hospitals worldwide, and causes substantial morbidity and mortality. Health-care-associated MRSA infections arise in individuals with predisposing risk factors, such as surgery or presence of an indwelling medical device. By contrast, many community-associated MRSA (CA-MRSA) infections arise in otherwise healthy individuals who do not have such risk factors. Additionally, CA-MRSA infections are epidemic in some countries. These features suggest that CA-MRSA strains are more virulent and transmissible than are traditional hospital-associated MRSA strains. The restricted treatment options for CA-MRSA infections compound the effect of enhanced virulence and transmission. Although progress has been made towards understanding emergence of CA-MRSA, virulence, and treatment of infections, our knowledge remains incomplete. Here we review the most up-to-date knowledge and provide a perspective for the future prophylaxis or new treatments for CA-MRSA infections. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20206987      PMCID: PMC3511788          DOI: 10.1016/S0140-6736(09)61999-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  151 in total

Review 1.  Immune evasion by staphylococci.

Authors:  Timothy J Foster
Journal:  Nat Rev Microbiol       Date:  2005-12       Impact factor: 60.633

2.  Successful multiresistant community-associated methicillin-resistant Staphylococcus aureus lineage from Taipei, Taiwan, that carries either the novel Staphylococcal chromosome cassette mec (SCCmec) type VT or SCCmec type IV.

Authors:  Susan Boyle-Vavra; Ben Ereshefsky; Chih-Chien Wang; Robert S Daum
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

3.  Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections.

Authors:  John Weigelt; Kamal Itani; Dennis Stevens; William Lau; Matthew Dryden; Charles Knirsch
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

4.  The arginine catabolic mobile element and staphylococcal chromosomal cassette mec linkage: convergence of virulence and resistance in the USA300 clone of methicillin-resistant Staphylococcus aureus.

Authors:  Binh An Diep; Gregory G Stone; Li Basuino; Christopher J Graber; Alita Miller; Shelley-Ann des Etages; Alison Jones; Amy M Palazzolo-Ballance; Françoise Perdreau-Remington; George F Sensabaugh; Frank R DeLeo; Henry F Chambers
Journal:  J Infect Dis       Date:  2008-06-01       Impact factor: 5.226

5.  Phenol-soluble modulin alpha 3 enhances the human neutrophil lysis mediated by Panton-Valentine leukocidin.

Authors:  Isamu Hongo; Tadashi Baba; Kanenari Oishi; Yuh Morimoto; Teruyo Ito; Keiichi Hiramatsu
Journal:  J Infect Dis       Date:  2009-09-01       Impact factor: 5.226

6.  Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection.

Authors:  N Markowitz; E L Quinn; L D Saravolatz
Journal:  Ann Intern Med       Date:  1992-09-01       Impact factor: 25.391

7.  Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus infection.

Authors:  Priya M Rajendran; David Young; Toby Maurer; Henry Chambers; Francoise Perdreau-Remington; Peter Ro; Hobart Harris
Journal:  Antimicrob Agents Chemother       Date:  2007-09-10       Impact factor: 5.191

8.  The survival of staphylococci within human leukocytes.

Authors:  D E ROGERS; R TOMPSETT
Journal:  J Exp Med       Date:  1952-02       Impact factor: 14.307

9.  Global distribution of Panton-Valentine leukocidin--positive methicillin-resistant Staphylococcus aureus, 2006.

Authors:  Anne Tristan; Michele Bes; Helene Meugnier; Gerard Lina; Bülent Bozdogan; Patrice Courvalin; Marie-Elisabeth Reverdy; Mark C Enright; François Vandenesch; Jerome Etienne
Journal:  Emerg Infect Dis       Date:  2007-04       Impact factor: 6.883

10.  Methicillin-resistant Staphylococcus aureus clones, Western Australia.

Authors:  Geoffrey W Coombs; Julie C Pearson; Frances G O'Brien; Ronan J Murray; Warren B Grubb; Keryn J Christiansen
Journal:  Emerg Infect Dis       Date:  2006-02       Impact factor: 6.883

View more
  503 in total

1.  ABI domain-containing proteins contribute to surface protein display and cell division in Staphylococcus aureus.

Authors:  Matthew B Frankel; Brandon M Wojcik; Andrea C DeDent; Dominique M Missiakas; Olaf Schneewind
Journal:  Mol Microbiol       Date:  2010-10       Impact factor: 3.501

2.  Antimicrobial activity of community-associated methicillin-resistant Staphylococcus aureus is caused by phenol-soluble modulin derivatives.

Authors:  Hwang-Soo Joo; Gordon Y C Cheung; Michael Otto
Journal:  J Biol Chem       Date:  2011-01-28       Impact factor: 5.157

Review 3.  Exploring Staphylococcus aureus pathways to disease for vaccine development.

Authors:  Andrea DeDent; Hwan Keun Kim; Dominique Missiakas; Olaf Schneewind
Journal:  Semin Immunopathol       Date:  2011-12-01       Impact factor: 9.623

4.  Impact of results of a rapid Staphylococcus aureus diagnostic test on prescribing of antibiotics for patients with clustered gram-positive cocci in blood cultures.

Authors:  Jane Davies; Claire L Gordon; Steven Y C Tong; Robert W Baird; Joshua S Davis
Journal:  J Clin Microbiol       Date:  2012-04-04       Impact factor: 5.948

5.  Genome sequence of Staphylococcus aureus strain 11819-97, an ST80-IV European community-acquired methicillin-resistant isolate.

Authors:  Marc Stegger; Lance B Price; Anders R Larsen; John D Gillece; Andrew E Waters; Robert Skov; Paal S Andersen
Journal:  J Bacteriol       Date:  2012-03       Impact factor: 3.490

6.  Draft genome sequence of Staphylococcus aureus 118 (ST772), a major disease clone from India.

Authors:  Sushma Prabhakara; Supriya Khedkar; Ramya Malarini Loganathan; S Chandana; Malali Gowda; Gayathri Arakere; Aswin Sai Narain Seshasayee
Journal:  J Bacteriol       Date:  2012-07       Impact factor: 3.490

7.  Subinhibitory concentrations of protein synthesis-inhibiting antibiotics promote increased expression of the agr virulence regulator and production of phenol-soluble modulin cytolysins in community-associated methicillin-resistant Staphylococcus aureus.

Authors:  Hwang-Soo Joo; June L Chan; Gordon Y C Cheung; Michael Otto
Journal:  Antimicrob Agents Chemother       Date:  2010-08-16       Impact factor: 5.191

8.  A conformational switch involved in maturation of Staphylococcus aureus bacteriophage 80α capsids.

Authors:  Michael S Spilman; Altaira D Dearborn; Jenny R Chang; Priyadarshan K Damle; Gail E Christie; Terje Dokland
Journal:  J Mol Biol       Date:  2010-12-01       Impact factor: 5.469

9.  Methicillin-resistant Staphylococcus aureus bacterial nitric-oxide synthase affects antibiotic sensitivity and skin abscess development.

Authors:  Nina M van Sorge; Federico C Beasley; Ivan Gusarov; David J Gonzalez; Maren von Köckritz-Blickwede; Sabina Anik; Andrew W Borkowski; Pieter C Dorrestein; Evgeny Nudler; Victor Nizet
Journal:  J Biol Chem       Date:  2013-01-15       Impact factor: 5.157

10.  Structural characterization of native autoinducing peptides and abiotic analogues reveals key features essential for activation and inhibition of an AgrC quorum sensing receptor in Staphylococcus aureus.

Authors:  Yftah Tal-Gan; Monika Ivancic; Gabriel Cornilescu; Claudia C Cornilescu; Helen E Blackwell
Journal:  J Am Chem Soc       Date:  2013-11-25       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.